Biotech developer and supplier of microspheres for liver cancer treatment.
On open was down more than 50% on profit downgrade guidance, currently down 35%
Chart was a warning in hindsight
Better than Bellamy, still isn't Sirtex still likely to trade higher?
I thought price drop was beucase they another company developed or are developing a similar product.
